IRIS – Institutional Research Information System

IRIS è il sistema di gestione della ricerca dell’Università degli Studi di Milano-Bicocca.
Il repository BOA è il modulo del sistema dedicato alla raccolta e alla disseminazione della produzione scientifica di Ateneo. Le pubblicazioni sono ricercabili per parola chiave attraverso il box nella barra orizzontale in alto oppure, mediante il pulsante Sfoglia, per "Afferenza", "Autore", "Titolo", "Tipologia" o "Settore scientifico-disciplinare".
IRIS contiene inoltre alcuni moduli dedicati alla registrazione dei progetti e dei contratti, e alla reportistica avanzata per le attività di valutazione della ricerca

BOA Bicocca Open Archive

Pagina ricercatore

English

Italiano

English

TREVISAN, ROBERTO

Rete di Collaborazioni Statistiche Email Alert RSS Feed

Dettaglio

Nome completo

TREVISAN, ROBERTO

Afferenza

DIPARTIMENTO DI MEDICINA E CHIRURGIA (SCHOOL OF MEDICINE AND SURGERY)

Pubblicazioni

Tutti (108)

RIS

EndNote

BibTeX

RefWorks

Excel

Risultati 1 - 20 di 108 (tempo di esecuzione: 0.001 secondi).

1

2

3

4

5

6

Titolo Data di pubblicazione Autori
1 Atrial natriuretic factor in hypertensive and normotensive insulin-dependent diabetics 1989 Opocher, G; Mantero, F; Rocco, S; TREVISAN, ROBERTO ; Fioretto, P; Semplicini, A; Morocuttit, A; Zanette, G; Donadon, V; Perico, N; Giorato, C; Carraro, A

2 Effect of low-dose ramipril on microalbuminuria in normotensive or mild hypertensive non-insulin-dependent diabetic patients. North-East Italy Microalbuminuria Study Group 1995 TREVISAN, ROBERTO ; Tiengo A

3 Enhanced effects of insulin and angiotensin II on intracellular pH and free cytosolic calcium in fibroblasts from microalbuminuric patients with non-insulin dependent diabetes mellitus 1996 TREVISAN, ROBERTO ; Duner E; Cipollina MR; DiVirgilio F; Trevisan M; Nosadini R

4 Sodium-hydrogen antiporter: Its possible role in the genesis of diabetic nephropathy 1997 TREVISAN, ROBERTO ; Viberti G

5 Enhanced responsiveness of blood pressure to sodium intake and to angiotensin II is associated with insulin resistance in IDDM patients with microalbuminuria 1998 TREVISAN, ROBERTO ; Bruttomesso D; Vedovato M; Brocco S; Pianta A; Mazzon C; Girardi C; Jori E; Semplicini A; Tiengo A; Del Prato S

6 Modulatory effect of insulin on release of calcium from human fibroblasts by angiotensin II 1998 Ceolotto G; Pessina AC; Iori E; Monari A; TREVISAN, ROBERTO ; Winkleswski P; Semplicini A

7 A PC-1 amino acid variant (K121Q) is associated with faster progression of renal disease in patients with type 1 diabetes and albuminuria 2000 De Cosmo S; Argiolas A; Miscio G; Thomas S; Piras GP; TREVISAN, ROBERTO ; Perin PC; Bacci S; Zucaro L; Margaglione M; Frittitta L; Pizzuti A; Tassi V; Viberti GC; Trischitta V

8 Effect of insulin and angiotensin II on cell calcium in human skin fibroblasts 2001 Ceolotto G; Valente R; Baritono E; Reato S; Iori E; Monari A; TREVISAN, ROBERTO ; Semplicini A

9 The decorin gene 179 allelic variant is associated with a slower progression of renal disease in patients with type 1 diabetes 2002 De Cosmo S; Tassi V; Thomas S; Piras GP; TREVISAN, ROBERTO ; Perin PC; Bacci S; Zucaro L; Cisternino C; Trischitta V; Viberti GC

10 Cost-effectiveness of two screening programs for microalbuminuria in type 2 diabetes 2002 Lepore G; Maglio ML; Nosari I; Dodesini AR; TREVISAN, ROBERTO

11 In situ protein Kinase C activity is increased in cultured fibroblasts from Type 1 diabetic patients with nephropathy 2003 Lori E; Marescotti MC; Vedovato M; Ceolotto G; Avogaro A; Tiengo A; Del Prato S; TREVISAN, ROBERTO

12 PC-1 amino acid variant Q121 is associated with a lower glomerular filtration rate in type 2 diabetic patients with abnormal albumin excretion rates 2003 De Cosmo S; TREVISAN, ROBERTO ; Dalla Vestra M; Vedovato M; Argiolas A; Solini A; Saller A; Damone F; Tiengo A; Trischitta V; Fioretto P

13 Ronal and metabolic effects of insulin lispro in type 2 diabetic sublects with overt nephropathy 2003 Ruggenenti P; Flores C; Aros C; Ene-Iordache B; TREVISAN, ROBERTO ; Ottomano C; Remuzzi G

14 Lipids and renal disease 2006 TREVISAN, ROBERTO ; Dodesini AR; Lepore G

15 Poor glucose control in the year before admission as a powerful predictor of amputation in hospitalized patients with diabetic foot ulceration 2006 Lepore G; Maglio ML; Cuni C; Dodesini AR; Nosari I; Minetti B; TREVISAN, ROBERTO

16 Lower fasting blood glucose, glucose variability and nocturnal hypoglycaemia with glargine vs NPH basal insulin in subjects with Type 1 diabetes 2009 Bolli GB; Songini M; Trovati M; Del Prato S; Ghirlanda G; Cordera R; TREVISAN, ROBERTO ; Riccardi G; Noacco C

17 Effect of Trandolapril on Regression of Retinopathy in Hypertensive Patients with Type 2 Diabetes: A Prespecified Analysis of the Benedict Trial 2010 Ruggenenti P; Iliev I; Filipponi M; Tadini S; Perna A; Ganeva M; Ene-Iordache B; Cravedi P; TREVISAN, ROBERTO ; Bossi A; Remuzzi G

18 Continuous subcutaneous insulin infusion is better than multiple daily insulin injections in reducing glucose variability only in type 1 diabetes with good metabolic control 2010 Lepore G; Corsi A; Dodesini AR; Nosari I; TREVISAN, ROBERTO

19 Effects of Manidipine and Delapril in Hypertensive Patients With Type 2 Diabetes Mellitus: The Delapril and Manidipine for Nephroprotection in Diabetes (DEMAND) Randomized Clinical Trial 2011 Ruggenenti, P; Lauria, G; Iliev, IP; Fassi, A; Ilieva, AP; Rota, S; Chiurchiu, C; Barlovic, DP; Sghirlanzoni, A; Lombardi, R; Penza, P; CAVALETTI, GUIDO ANGELO ; Piatti, ML; Frigeni, B; Filipponi, M; Rubis, N; Noris, G; Motterlini, N; Ene Iordache, B; Gaspari, F; Perna, A; Zaletel, J; Bossi, A; Dodesini, AR; TREVISAN, ROBERTO ; Remuzzi, G; DEMAND Study Investigators; Remuzzi, G; Ruggenenti, P; Bossi, A; Parvanova, IA; Petrov, II; Yakymchuk, S; Chiurchiu, C; Rota, S; Arnoldi, F; Prandini, S; Kocijancic, A; Zaletel, J; Pongrac, D; Prezelj, J; Gala, T; Kersnik, M; Trevisan, G; Lepore, G; Fassi, A; Mondo, E; Inversi, F; Mangili, R; Bruno, S; Brusegan, V; Lecchi, V; Belviso, A; Genovese, S; Lauria, G; Sghirlanzoni, A; Pareyson, D; Lombardi, R; Camozzi, F; Penza, P; Cavaletti, G; Piatti, ML; Marzorati, L; MARMIROLI, PAOLA LORENA ; Frigeni, B; Mattavelli, L; Petrov, II; Filipponi, M; Tadini, S; Rubis, N; Gherardi, G; Calini, W; Diadei, O; Noris, G; Rossoni, D; Villa, D; Ene Iordache, B; Carminati, S; Agus, E; Remuzzi, A; Giuliano, GA; Perna, A; Motterlini, N; Ganeva, M; Gaspari, F; Cannata, AN; Carrara, F; Cella, C; Centemeri, E; Ferrari, S; Petrò, C; Savoldelli, E; Stucchi, N; Boccardo, P; Perico, N; Rubis, N; Peracchi, S; Gelmi, S; Remuzzi, G; Ruggenenti, P; Mecca, G; Perna, A; Sghirlanzoni, A; Imbimbo, B; Alberici, M; Gardini, F; Ruggenenti, P; Remuzzi, G; Filipponi, M; Petrov, II; Sghirlanzoni, A; Lauria, G.

20 The Remission Clinic approach to halt the progression of kidney disease 2011 Ruggenenti P; Remuzzi A; Remuzzi G; Perticucci E; TREVISAN, ROBERTO ; Dodesini A; Gambara V; Ene-Iordache B; Carminati S; Rubis N; Gherardi G; Perna A; Cravedi P

1

2

3

4

5

6

Powered by IRIS-about IRIS-Utilizzo dei cookie-Privacy

Copyright © 2022